During the past decade, Genesis Healthcare System conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 28 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Genesis Healthcare System" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "Boston Scientific Corporation" with 6 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "SWOG Cancer Research Network" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Healthcare System" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "BTG International Inc." with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Genesis Healthcare System" are "Heart Failure" (4 trials), "Stress Urinary Incontinence" (2 trials), "Acral Lentiginous Malignant Melanoma" (1 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Genesis Healthcare System" in a lesser frequency.

Most popular intervention types in "Genesis Healthcare System" are "Drug" (24 trials), "Other" (11 trials), "Biological" (9 trials), "Device" (9 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (6 trials), "Laboratory Biomarker Analysis" (5 trials), "Akt Inhibitor MK2206" (3 trials), "Carboplatin" (3 trials) and "cetuximab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Healthcare System" are 30 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Genesis Healthcare System". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Genesis Healthcare System, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Healthcare System, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".